L. Salazar Gómez and J. P. Grisales Negrete, “Molecular and clinical evidence of the cardiovascular benefit of SGLT2 inhibitors: State of the art”, Med UPB, vol. 41, no. 2, pp. 145–156, Aug. 2022, doi: 10.18566/medupb.v41n2.a07.